Ribo Nucleic Acid (RNA) interference is a cellular therapy designed to target specific cells such as cancer cells or infected cells. The process involves drawing the patient’s blood. For cancer cells, the number of circulating tumor cells are identified. For infected cells, 50 viruses and 14 bacteria are screened, identified, and amplified into a genome. We receive the results as a powder which we dissolve into an IV and administer to the patient.
A circulating tumor cell, CTC, is a cell that has shed into the vasculature or lymphatics from a primary tumor and is carried around the body in the blood circulation. RNAi therapy identifies the circulating tumor cells identified as specific to the patient. The RNAi therapy infuses into these cells, transcribes the DNA into the messenger RNA with the message to inactivate the cell (apoptosis, also known as a cell programmed death) so it can destroy all the identified circulating tumor cells.
For an infected cell, the RNAi therapy identifies the virus or bacteria, transcribes the nucelic DNA or RNA into the cellular messenger RNA with instruction to inactivate cell (apoptosis a programmed cell death) so it can destros all the identified infected viral and/or bacterial cells.
Note for cancer, this is a supportive therapy and not an approved FDA drug such as chemotherapy, radiation or surgery.
Health Issues We Treat
- Lyme Disease
- Epstein-Barr Virus (EBV)
- 50 viral and 14 bacterial infections
- Supportive therapy – Note this is supportive therapy to cancer that is experimental and not an approved FDA drug. Chemotherapy, radiation and surgery are only approved therapies for cancer by the FDA.
How We Use It in Our Practice
Call us at 888-299-4570 or email firstname.lastname@example.org to discuss your questions about RNAi.